Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2

The Journal of Applied Laboratory Medicine(2021)10.1093/jalm/jfab072Source: DataRank Database

Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2 is a research paper published in The Journal of Applied Laboratory Medicine (2021). On theSindex it has a DataRank of 0.464. It has been cited 21 times.

N/A

0.464DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 1.22)OA: bronzeTopics (49)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.464

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (17)

Elizabeth W. Karlson ORCID,Maia Norman ORCID,Tal Gilboa ORCID,Stephanie Fischinger ORCID,Caroline Atyeo ORCID

Live enrichment

PubMed:34196711 PMC:PMC8420636 OpenAlex:https://openalex.org/W3177283115

National Institutes of Health

Grant: UL1TR001102

Centers for Disease Control and Prevention

Grant: U01 GH002238

National Institutes of Health

Grant: U01 HG008685

National Institutes of Health

Grant: OT2OD026553

National Institutes of Health

Grant: P30 AR070253

NIH

Grant: K08 AR075850

NIH

Grant: UM1AI069412

National Institutes of Health

Grant: 1OT2OD026553-01

The New England Precision Medicine Consortium of the All of Us Research Program

National Institutes of Health

Grant: 6U01GH002238-02M002

Reducing the morbidity and mortality due to acute febrile illnesses in Central America and the Dominican Republic

National Institutes of Health

Grant: 2UM1AI069412-08

Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)

National Institutes of Health

Grant: 5K08AR075850-05

SLAMF7 Regulates Synovial Macrophages in Rheumatoid Arthritis

National Institutes of Health

Grant: 5P30AR070253-04

Joint Biology Consortium Resource-based Center

National Institutes of Health

Grant: 4UL1TR001102-04

Harvard Clinical and Translational Science Center

National Institutes of Health

Grant: 1U01HG008685-01

EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE

Massachusetts Consortium on Pathogen Readiness

Chleck Foundation

FWCI

1.22

Citation Percentile

0.8%

Influential Citations

Citation Trend

2020

2021

2022

2023

2024

2025

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/jalm/article-pdf/6/6/1561/41046967/jfab072.pdf

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325183

publisherhttps://academic.oup.com/jalm/article-pdf/6/6/1561/41046967/jfab072.pdf

publisherhttp://academic.oup.com/jalm/advance-article-pdf/doi/10.1093/jalm/jfab072/40435152/jfab072.pdf

publisherhttp://academic.oup.com/jalm/article-pdf/6/6/1561/41046967/jfab072.pdf

Fields of Study

SARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMedicine0301 basic medicine0303 health sciences03 medical and health sciencesAntibodies, ViralCOVID-19COVID-19 Serological TestingHumansImmunoassayImmunoglobulin GImmunoglobulin MSARS-CoV-2Sensitivity and Specificity

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Serological TestingAntibodies, ViralHumansImmunoglobulin GImmunoglobulin MImmunoassaySensitivity and Specificity

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakMedicineComputer scienceOutbreakInternal medicineInfectious disease (medical specialty)AntibodiesSerologySensitivitySpecificityPerformanceImmunoassaysCovid-19Sars-cov-2ImmunoassayImmunoglobulin MImmunoglobulin GHumansAntibodies, ViralSensitivity and SpecificityCOVID-19 Serological Testing

Sustainable Development Goals

SDG 0: Good health and well-being